Patient: Page 20
-
Precision Medicine Meets Precision Patient Support
In the value-driven healthcare environment, orphan drug manufacturers are becoming increasingly aware that improving adherence requires a new approach to patient understanding and support. Take for example the required lifestyle, nutritional or physical modifications often necessary for patient c...
By Kathi Henson • Oct. 1, 2017 -
Impact Patient Outcomes Without Talking to the Patient
Patient marketers are used to providing valuable patient services and information directly to patients. But if the goal is to accelerate patient outcomes, the needs of the caregiver should also be addressed. Patient marketers know that caregivers play an important part in patients’ lives, but the...
By Andi Weiss • Oct. 1, 2017 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
The Connected Consumer
At some point during the far-off days of the Carter administration, Carnegie Mellon expanded its Computer Science department, leaving programmers farther away from the department’s only Coke machine. So rather than trek down a couple of floors only to find an empty vending machine, or worse, a ma...
By Johanna Skilling • Oct. 1, 2017 -
Letter from the Editor
Patients as people The term patient-centricity has been used so frequently — including in the pages of PharmaVOICE — that it has almost begun to lose meaning … almost. Patient empowerment began to erode the traditional power center of medicine — the doctor — with the first direct-to-consumer adve...
By Taren Grom • Sept. 1, 2017 -
The Future of Patient-Focused Marketing from the Agency C-Suite
Marketers in the life-sciences field are facing ever-evolving challenges to meet ever-changing patient expectations. According to one recent study, 77% of patients start their health journey online beginning at a search engine. This action alone provides marketers huge opportunities as well as ch...
By PharmaVoice Team • Sept. 1, 2017 -
Patient-Centered Trials
Researchers, physicians, pharma, and biotech developers all want to do the right thing for patients. Everyone in the industry understands the need to develop transformative therapies for those with disease. But historically, patients have often been invisible. Although patients are the ultimate c...
By PharmaVoice Team • Sept. 1, 2017 -
The Patient Advocates
Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...
By PharmaVoice Team • Aug. 1, 2017 -
Last Word
Bringing Patients’ Voices to Drug Development Sudip Parikh, Senior VP and Managing Director of DIA Americas, talks about the Drug Information Association’s survey of patient-centric initiatives in drug development. PV: What are the notable findings fromDIA’s survey about patient-centricity in dr...
By Sudip Parikh • June 1, 2017 -
Improved Patient-Centricity Means Improved Patient Diversity Too
Increasing the diversity of patients enrolled in clinical trials of new medicines has become a growing theme for improving the clinical trial process. There is broad recognition that research participants need to be representative of the patient population who will ultimately use the product. Res...
By Scott Gray • June 1, 2017 -
eConsent: Reducing Uncertainty to Retain Patients
Imagine you’re applying for a new bank account. A bank associate guides you through forms, pointing at where your signature belongs. He’s got good intentions and wants to help, but speaks quickly with jargon and acronyms. You leave feeling cautiously optimistic, as you still have questions. Weeks...
By Eric Delente • June 1, 2017 -
HBA Rising Stars & Luminaries: A Vision of the Future
PharmaVOICE asked the nearly 100 industry executives identified by their companies as HBA Rising Stars and Luminaries to identify the biggest trends they believe will impact the industry in the next few years. Top on their lists are innovation and value. They also tackle the topics of big data, p...
By PharmaVoice Team • May 1, 2017 -
Rare Recruitment
Efforts to bring treatments to market for the approximately 7,000 rare diseases affecting more than 350 million people globally have been stepped up in recent years. But in order to bring products to market, companies must conduct clinical trials with a large enough patient population — relative ...
By Kim Ribbink • May 1, 2017 -
Patient Stories
As the industry continues to embrace a more patient-centric business model, patient views have shifted to the forefront of several strategies, including using patient advisory boards for drug development and clinical trial protocols, and patient stories and communities to guide marketing and othe...
By Robin Robinson • March 1, 2017 -
Partnering for More Impactful Patient Recruitment Services
Sponsors of global clinical trials increasingly need a strategic partner for their patient enrollment challenges, as opposed to enlisting an array of outsourced tactical vendors through a standard RFP process. Why have such partnerships become critical for on-time trial completion? There are a nu...
By Elaina N. Haeuber • Feb. 1, 2017 -
mHealth
Remote Patient Monitoring Device Market to Reach $1.5 Billion by 2024 Trending Now: From smart bras to inhalers, remote monitoring devices continue to gain traction. Cardiovascular Diseases, Respiratory Disorders, and Diabetes Drive Growth in Global Remote Patient Monitoring Device Market Accord...
By PharmaVoice Team • Nov. 21, 2016 -
Trending 2017: Gene Editing
The development of human therapeutics using gene editing technologies is an area of major interest that has recently received large public and private investments. The initial applications of gene editing technologies have largely focused on the treatment of monogenic disorders, but other areas, ...
By PharmaVoice Team • Nov. 21, 2016 -
Trending 2017: Health Bots
Over the past several years, technological innovations in the healthcare industry have come and gone, but only a handful of trends have matured and achieved widespread adoption among healthcare organizations, according to experts at TechTarget, who add that bots are another new development that i...
By PharmaVoice Team • Nov. 21, 2016 -
Trending 2017: Precision Medicine
Precision medicine holds great promise for improving patient health outcomes. By identifying genetic causes of diseases, doctors can focus on disease prevention, earlier diagnosis when treatments may be more effective, and avoid giving treatments to patients that may cause adverse reactions or th...
By PharmaVoice Team • Nov. 21, 2016 -
The Evolution of Patient Communities
Patient and community outreach have changed over the last decade. Patient organizations and pharmaceutical companies have been building communities, especially online communities of patients, because they recognize the opportunity to provide support and information exchange. Social media has had ...
By Denise Myshko • Oct. 1, 2016 -
French Connection: Picture of an Evolving Market
France is the second-largest European market and one of the world’s largest consumers of pharmaceutical products. The French pharmaceutical industry grew by 17.9% between 2000 and 2010, compared with growth of 6.1% in the manufacturing sector. This performance can be explained by solid scientific...
By Kim Ribbink • Oct. 1, 2016 -
SHOWCASE FEATURE: Patient Solutions: Patients Are No Longer Patient for Solutions
Over the past few years, the term patient-centric has been used so frequently that it almost has no meaning. But despite the centricity over the concept, the strategy of putting patients squarely in the middle of what the industry is doing and where it needs to go is sound. In parallel, the conce...
By Taren Grom • Oct. 1, 2016 -
Helping Patients Help Themselves
One of the biggest challenges in healthcare begins the moment a patient steps out of the doctor’s office or clinic. Suddenly, that individual assumes the bulk of responsibility for managing his or her condition on a daily basis — day after day, good mood or bad, on vacations, at work and at home....
By Jennifer Sigaud • Oct. 1, 2016 -
Creating a More Efficient, Effective, and Easier Model for Patient Care
It’s a challenge that continues to keep many pharmaceutical leaders up at night: how to advance patient-oriented programs in an industry addicted to the use of middlemen. A myriad of players, including PBMs (pharmacy benefit managers), wholesalers, specialty pharmacies, and other “hub" service co...
By Marie Lamont • Oct. 1, 2016 -
Addressing Whole Patient Needs: A New Model for Pharma
In today’s healthcare environment, there is more pressure to deliver optimal patient outcomes with greater efficiency. Traditional marketing approaches that rely on messaging to promote patient acceptance of therapy and adherence are not enough to drive real-world impact. To stay relevant, the ph...
By Jessica Brueggeman • Oct. 1, 2016 -
Not "Patients," But People
Finding Inspiration on Customer-Centric Marketing From Other Walks of Life Let’s not be healthcare marketers for a moment. Let’s be us: men, women, parents, grandparents, grandchildren, children, aunts, uncles, even pet parents. Sometimes we get sick. Our loved ones may suffer a heart attack. Alz...
By Johanna Skilling • Oct. 1, 2016